Hsiu-Nien Shen1,2, Chun-Chieh Yang1, Ya-Hui Chang2, Chin-Li Lu2, Chung-Yi Li2,3. 1. Department of Intensive Care Medicine, Chi Mei Medical Center, Yong-Kang District, Tainan, Taiwan. 2. Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan. 3. Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan.
Abstract
OBJECTIVES: Population-based data on the risk of diabetes mellitus onset after acute pancreatitis (AP) are lacking. We assessed the incidence of diabetes in AP survivors compared with matched controls. METHODS: The study cohort, drawn from Taiwan National Health Insurance claims data, included 2,966 first-attack AP patients and 11,864 non-AP general controls individually matched on age and sex, with an AP/non-AP ratio of 1:4. Incidence rate was estimated under Poisson assumption. Relative risks of diabetes were indicated by hazard ratios (HRs) estimated from Cox proportional hazard regression models with a partitioning of time at 3 months to account for proportionality. RESULTS: In the first partition of time (<3 months), the incidences of diabetes were 60.8 and 8.0 per 1,000 person-years in AP and control groups, respectively; representing a covariate-adjusted HR of 5.90 (95% confidence interval (CI) 3.37-10.34). In the second partition (≥3 months), the incidences of diabetes were 22.5 and 6.7 per 1,000 person-years in AP and control groups, respectively (adjusted HR 2.54, 95% CI 2.13-3.04). In the second partition, the risk of diabetes was greater in men than in women (HR 3.21 vs. 1.58, P=0.0004). When the analyses were stratified by severity of AP, the results for mild AP were similar to those for all AP. CONCLUSIONS: The risk of diabetes increases by twofold after AP; therefore, a long-term screening is necessary to evaluate diabetes after an attack regardless of severity. Further research should be conducted to develop cost-effective follow-up strategies, and to elucidate the underlying mechanisms of the relationship between diabetes and AP.
OBJECTIVES: Population-based data on the risk of diabetes mellitus onset after acute pancreatitis (AP) are lacking. We assessed the incidence of diabetes in AP survivors compared with matched controls. METHODS: The study cohort, drawn from Taiwan National Health Insurance claims data, included 2,966 first-attack AP patients and 11,864 non-AP general controls individually matched on age and sex, with an AP/non-AP ratio of 1:4. Incidence rate was estimated under Poisson assumption. Relative risks of diabetes were indicated by hazard ratios (HRs) estimated from Cox proportional hazard regression models with a partitioning of time at 3 months to account for proportionality. RESULTS: In the first partition of time (<3 months), the incidences of diabetes were 60.8 and 8.0 per 1,000 person-years in AP and control groups, respectively; representing a covariate-adjusted HR of 5.90 (95% confidence interval (CI) 3.37-10.34). In the second partition (≥3 months), the incidences of diabetes were 22.5 and 6.7 per 1,000 person-years in AP and control groups, respectively (adjusted HR 2.54, 95% CI 2.13-3.04). In the second partition, the risk of diabetes was greater in men than in women (HR 3.21 vs. 1.58, P=0.0004). When the analyses were stratified by severity of AP, the results for mild AP were similar to those for all AP. CONCLUSIONS: The risk of diabetes increases by twofold after AP; therefore, a long-term screening is necessary to evaluate diabetes after an attack regardless of severity. Further research should be conducted to develop cost-effective follow-up strategies, and to elucidate the underlying mechanisms of the relationship between diabetes and AP.
Authors: Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto Journal: Lancet Date: 2006-11-11 Impact factor: 79.321
Authors: Stephanie L M Das; Primal P Singh; Anthony R J Phillips; Rinki Murphy; John A Windsor; Maxim S Petrov Journal: Gut Date: 2013-08-08 Impact factor: 23.059
Authors: Søren S Olesen; Jakob L Poulsen; Srdan Novovic; Camilla Nøjgaard; Evangelos Kalaitzakis; Nanna M Jensen; Trond Engjom; Erling Tjora; Anne Waage; Truls Hauge; Stephan L Haas; Miroslav Vujasinovic; Giedrius Barauskas; Aldis Pukitis; Imanta Ozola-Zālīte; Alexey Okhlobystin; Mikael Parhiala; Johanna Laukkarinen; Asbjørn M Drewes Journal: United European Gastroenterol J Date: 2020-01-17 Impact factor: 4.623
Authors: Stephen A Firkins; Phil A Hart; Georgios I Papachristou; Luis F Lara; Zobeida Cruz-Monserrate; Alice Hinton; Darwin L Conwell; David P Bradley; Somashekar G Krishna Journal: Pancreas Date: 2021 May-Jun 01 Impact factor: 3.327
Authors: Phil A Hart; David Bradley; Darwin L Conwell; Kathleen Dungan; Somashekar G Krishna; Kathleen Wyne; Melena D Bellin; Dhiraj Yadav; Dana K Andersen; Jose Serrano; Georgios I Papachristou Journal: Lancet Gastroenterol Hepatol Date: 2021-06-03